Hasnyálmirigyrák: vizsgálatok itt: Egyesült Államok
404 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Where
- Atlanta, Buffalo, Cleveland, Fairfax, Grand Rapids, Hackensack, Irving, Jefferson, New York, Santa Monica, St Louis
- Életkor
- 18 év and over
- People
- 404 worldwide
- Run by
- Astellas Pharma Inc
See details and how to joinNCT07094204 · EU 2025-522082-29-00 - Korai 1. fázisTaking peoplePilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer
- Where
- New Hyde Park
- Életkor
- 18 év and over
- People
- 10
- Run by
- Northwell Health
See details and how to joinNCT07254091 - 1. fázisTaking peopleSamuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 15
- Run by
- University of Washington
See details and how to joinNCT07645651 - 2. fázisTaking peopleSMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial
- Where
- Chicago
- Életkor
- 18 év and over
- People
- 125
- Run by
- Northwestern University
See details and how to joinNCT07748611 - 1/2. fázisBefejeződöttBOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Santa Monica, Tampa
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820 · EU 2024-517500-11-00 - 1. fázisTaking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Lake Success, Los Angeles, Portland, West Valley City
- Életkor
- 18 év and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - 1/2. fázisTaking peopleLead-212 PSV359 Therapy for Patients With Solid Tumors
- Where
- Cleveland, Columbus, Dallas, Houston, Kansas City, Lexington, Los Angeles, Madison, Miami, New York, Omaha, Pittsburgh, Rochester, St Louis
- Életkor
- 18 év to 90 év
- People
- 112
- Run by
- Perspective Therapeutics
See details and how to joinNCT06710756 - 1/2. fázisTaking people[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Where
- Dallas, New York
- Életkor
- 18 év to 80 év
- People
- 71
- Run by
- Blue Earth Diagnostics
See details and how to joinNCT07432633 - 3. fázisCsak meghívásosLong-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
- Where
- Bay Shore, Houston, Kettering, Memphis
- People
- 5000
- Run by
- Exelixis
See details and how to joinNCT07620574 · EU 2026-525795-26-00 - 1. fázisTaking peopleA Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Életkor
- 18 év and over
- People
- 20
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07671339 - No phaseTaking peoplectDNA Assay in Patients With Resectable Pancreatic Cancer
- Where
- Oklahoma City, Tulsa
- Életkor
- 18 év to 99 év
- People
- 50
- Run by
- University of Oklahoma
See details and how to joinNCT05052671 - 1. fázisTaking peopleFirst in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer
- Where
- Houston
- Életkor
- 18 év and over
- People
- 40
- Run by
- ParVation Therapeutics, Inc.
See details and how to joinNCT07756281 - 1. fázisNot yet taking people in Egyesült ÁllamokDaraxonrasib in Resectable PDAC
- Where
- Boston
- Életkor
- 18 év and over
- People
- 30
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07898813 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amarillo, Chattanooga, Dallas, Fairfax, Germantown, Los Angeles, Minneapolis, Nashville, New York, Pearland, Salt Lake City, Skokie, Wenatchee, Westbury, White Plains, Whittier
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1. fázisTaking peopleA Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Where
- Boston, Durham, Fairfax, Houston, Nashville, New York, Orlando, San Antonio, St Louis, Tampa
- Életkor
- 18 év and over
- People
- 448
- Run by
- Alterome Therapeutics, Inc.
See details and how to joinNCT06835569 - 1/2. fázisTaking peopleJAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- Where
- Cleveland, Rochester, Salt Lake City, St Louis
- Életkor
- 18 év and over
- People
- 344
- Run by
- Jacobio Pharmaceuticals Co., Ltd.
See details and how to joinNCT06973564 - 2. fázisTaking peopleA Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Életkor
- 18 év and over
- People
- 122
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07895498 - 1/2. fázisTaking peopleStudy to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Where
- Boston, Chapel Hill, Chicago, Denver, Fairfax, Houston, Indianapolis, Iowa City, Irving, Jacksonville, New York, Omaha, Rochester, Salt Lake City, Scottsdale, Washington D.C.
- Életkor
- 18 év and over
- People
- 183
- Run by
- Tango Therapeutics, Inc.
See details and how to joinNCT06922591 - 3. fázisTaking peopleStudy of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Where
- Atlanta, Baltimore, Birmingham, Boston, Dallas, Durham, Fairfax, Hartford, Houston, Indianapolis, Jacksonville, Kansas City, La Jolla, Lakewood, Las Vegas, Lawrence, Longview, Los Angeles, Maumee, Miami, Miami Beach, Milwaukee, Nashville, New Brunswick, New York, Omaha, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Rochester, Sacramento, Salt Lake City, San Francisco, Scottsdale, Seattle, Sioux Falls, St. Petersburg
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07252232 · EU 2025-523495-23-00 - 1/2. fázisTaking peopleANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
- Where
- Los Angeles, Plantation, San Antonio
- Életkor
- 18 év and over
- People
- 84
- Run by
- Anova Innovation Limited
See details and how to joinNCT07444541 - 3. fázisTaking peopleThe Cancer of the Pancreas Screening-5 CAPS5)Study
- Where
- Ann Arbor, Baltimore, Boston, Cleveland, New Haven, New York, Philadelphia, Pittsburgh
- Életkor
- 18 év and over
- People
- 9000
- Run by
- Johns Hopkins University
See details and how to joinNCT02000089 - 1/2. fázisTaking peopleA Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Where
- Austin, Baton Rouge, Birmingham, Boston, Chattanooga, Cincinnati, Columbia, Dallas, Denver, East Syracuse, Fairfax, Flower Mound, Fort Myers, Hinsdale, Houston, Indianapolis, Jacksonville, Lake Success, Little Rock, Los Angeles, Maple Grove, Maumee, Memphis, Nashville, New York, Oklahoma City, Orlando, Philadelphia, Portland, Rochester, Salt Lake City, San Antonio, Santa Barbara, Santa Rosa, Sarasota, Scottsdale, Seattle, St Louis, Washington D.C., West Palm Beach
- Életkor
- 18 év and over
- People
- 542 worldwide
- Run by
- Artios Pharma Ltd
See details and how to joinNCT04657068 - 1/2. fázisTaking peopleTesting the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
- Where
- Pittsburgh
- Életkor
- 18 év and over
- People
- 31
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07619521 - 1. fázisTaking peopleA Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Where
- Houston, San Antonio, Scottsdale
- Életkor
- 18 év and over
- People
- 30
- Run by
- SHY Therapeutics
See details and how to joinNCT07705334 - No phaseTaking peopleReach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial
- Where
- Boston
- Életkor
- 18 év and over
- People
- 80
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT07787156